Genetic variants in rheumatic fever and rheumatic heart disease
- PMID: 32083395
- DOI: 10.1002/ajmg.c.31773
Genetic variants in rheumatic fever and rheumatic heart disease
Abstract
Genetic association studies in rheumatic heart disease (RHD) have the potential to contribute toward our understanding of the pathogenetic mechanism, and may shed light on controversies about RHD etiology. Furthermore, genetic association studies may uncover biomarkers that can be used to identify susceptible individuals, and contribute toward developing vaccine and novel therapeutic targets. Genetic predisposition to rheumatic fever and RHD has been hypothesized by findings from familial studies and observed associations between genes located in the human leukocyte antigens on chromosome 6p21.3 and elsewhere in the genome. We sought to summarize, from published Genetic association studies in RHD, evidence on genetic variants implicated in RHD susceptibility. Using HuGENet™ systematic review methods, we evaluated 66 studies reporting on 42 genes. Existing meta-analyses of candidate gene studies suggest that TGF-β1 [rs1800469], and IL-1β [rs2853550] single nucleotide polymorphisms (SNPs) contribute to susceptibility to RHD, whereas the TNF-α [rs1800629 and rs361525], TGF-β1 [rs1800470 and rs4803457], IL-6 [rs1800795], IL-10 [rs1800896] were not associated with RHD. However, candidate gene studies in RF/RHD are relatively small, thus lacking statistical power to identify reliable and reproducible findings, emphasizing the need for large-scale multicenter studies with different populations.
Keywords: genetics; polymorphisms; rheumatic fever; rheumatic heart disease.
© 2020 Wiley Periodicals, Inc.
Similar articles
-
Association study of inflammatory genes with rheumatic heart disease in North Indian population: A multi-analytical approach.Immunol Lett. 2016 Jun;174:53-62. doi: 10.1016/j.imlet.2016.04.012. Epub 2016 Apr 23. Immunol Lett. 2016. PMID: 27118427
-
Interleukin-10: Role in increasing susceptibility and pathogenesis of rheumatic fever/rheumatic heart disease.Cytokine. 2017 Feb;90:169-176. doi: 10.1016/j.cyto.2016.11.010. Epub 2016 Dec 3. Cytokine. 2017. PMID: 27918954 Review.
-
A study on the association of TNF-α(-308), IL-6(-174), IL-10(-1082) and IL-1Ra(VNTR) gene polymorphisms with rheumatic heart disease in Pakistani patients.Cytokine. 2013 Feb;61(2):527-31. doi: 10.1016/j.cyto.2012.10.020. Epub 2012 Nov 17. Cytokine. 2013. PMID: 23168096
-
Rheumatic fever and rheumatic heart disease: genetics and pathogenesis.Scand J Immunol. 2007 Aug-Sep;66(2-3):199-207. doi: 10.1111/j.1365-3083.2007.01974.x. Scand J Immunol. 2007. PMID: 17635797 Review.
-
Association study involving polymorphisms in IL-6, IL-1RA, and CTLA4 genes and rheumatic heart disease in New Zealand population of Māori and Pacific ancestry.Cytokine. 2016 Sep;85:201-6. doi: 10.1016/j.cyto.2016.06.029. Epub 2016 Jul 9. Cytokine. 2016. PMID: 27400406
Cited by
-
Hsa_circ_0000437 upregulates and promotes disease progression in rheumatic valvular heart disease.J Clin Lab Anal. 2022 Feb;36(2):e24197. doi: 10.1002/jcla.24197. Epub 2021 Dec 24. J Clin Lab Anal. 2022. PMID: 34952991 Free PMC article.
-
A Pilot Study of Associations Between the Occurrence of Palpitations and Cytokine Gene Variations in Women Prior to Breast Cancer Surgery.Biol Res Nurs. 2023 Apr;25(2):289-299. doi: 10.1177/10998004221134684. Epub 2022 Oct 18. Biol Res Nurs. 2023. PMID: 36255356 Free PMC article.
-
The Genetic Control of the Rheumatic Heart: Closing the Genotype-Phenotype Gap.Front Med (Lausanne). 2021 Mar 24;8:611036. doi: 10.3389/fmed.2021.611036. eCollection 2021. Front Med (Lausanne). 2021. PMID: 33842495 Free PMC article. Review.
-
The Immunomodulatory Role of Microbiota in Rheumatic Heart Disease: What Do We Know and What Can We Learn from Other Rheumatic Diseases?Medicina (Kaunas). 2023 Sep 8;59(9):1629. doi: 10.3390/medicina59091629. Medicina (Kaunas). 2023. PMID: 37763748 Free PMC article. Review.
-
Research priorities for the secondary prevention and management of acute rheumatic fever and rheumatic heart disease: a National Heart, Lung, and Blood Institute workshop report.BMJ Glob Health. 2023 Oct;8(Suppl 9):e012468. doi: 10.1136/bmjgh-2023-012468. BMJ Glob Health. 2023. PMID: 37914183 Free PMC article. Review.
References
REFERENCES
-
- Abdallah, A. M., Al-Mazroea, A. H., Al-Harbi, W. N., Al-Harbi, N. A., Eldardear, A. E., Almohammadi, Y., & Al-Harbi, K. M. (2016). Impact of MIF gene promoter variations on risk of rheumatic heart disease and its age of onset in Saudi Arabian patients. Frontiers in Immunology, 7, 98. https://doi.org/10.3389/fimmu.2016.00098
-
- Abdallah, A. M., Alnuzha, A., Al-Mazroea, A. H., Eldardear, A. E., AlSamman, A. Y., Almohammadi, Y., & Al-Harbi, K. M. (2016). IL10 promoter polymorphisms are associated with rheumatic heart disease in Saudi Arabian patients. Pediatric Cardiology, 37(1), 99-105. https://doi.org/10.1007/s00246-015-1245-y
-
- Aksoy, R., Duman, T., Keskin, O., & Duzgun, N. (2011). No association of PTPN22 R620W gene polymorphism with rheumatic heart disease and systemic lupus erythematosus. Molecular Biology Reports, 38(8), 5,393-5,396. https://doi.org/10.1007/s11033-011-0692-7
-
- Al-Harbi, K. M., Almuzaini, I. S., Morsy, M. M., Abdelaziz, N. A., Al-Balawi, A. M., & Abdallah, A. M. (2015). Angiotensin-converting enzyme gene insertion/deletion polymorphism in Saudi patients with rheumatic heart disease. Saudi Medical Journal, 36(2), 176-180. https://doi.org/10.15537/smj.2015.2.10267
-
- Atalar, E., Tokgozoglu, S. L., Alikasifoglu, M., Ovunc, K., Aksoyek, S., Kes, S., & Tuncbilek, E. (2003). Angiotensin-converting enzyme genotype predicts valve damage in acute rheumatic fever. The Journal of Heart Valve Disease, 12(1), 7-10 Retrieved from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed...
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous